CVS Health (CVS) Insider Trading & Ownership $65.49 +1.91 (+3.00%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$65.52 +0.03 (+0.05%) As of 08/8/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CVS Health (NYSE:CVS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage1.22%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$2.10MNumber OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$498.49K Get CVS Insider Trade Alerts Want to know when executives and insiders are buying or selling CVS Health stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address CVS Insider Buying and Selling by Quarter CVS Health Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/27/2025Michael T. McCaulU.S. Congress Member (R-TX)Sell$68.50$100,001 - $250,0006/5/2025Guy P SansoneDirectorBuy1,570$63.70$100,009.00 5/28/2025Ro KhannaU.S. Congress Member (D-CA)Sell$62.40$1,001 - $15,0005/19/2025Ro KhannaU.S. Congress Member (D-CA)Sell$62.71$1,001 - $15,0005/15/2025Robert Bresnahan, Jr.U.S. Congress Member (R-PA)Sell$60.42$1,001 - $15,0005/12/2025Jefferson ShreveU.S. Congress Member (R-IN)Sell$64.74$15,001 - $50,0004/10/2025Michael T. McCaulU.S. Congress Member (R-TX)Sell$68.86$100,001 - $250,0004/1/2025Julie JohnsonU.S. Congress Member (D-TX)Sell$67.88$1,001 - $15,0003/5/2025James David ClarkSVPSell7,513$66.35$498,487.55 2/25/2025Robert Bresnahan, Jr.U.S. Congress Member (R-PA)Buy$63.65$1,001 - $15,0002/18/2025Michael F MahoneyDirectorBuy30,000$66.70$2,001,000.00 (Data available from 1/1/2013 forward) CVS Insider Trading Activity - Frequently Asked Questions Who is on CVS Health's Insider Roster? The list of insiders at CVS Health includes Edward J Ludwig, Guy P Sansone, James David Clark, Karen S Lynch, Michael F Mahoney, Prem S Shah, and Thomas M Moriarty. Learn more on insiders at CVS. What percentage of CVS Health stock is owned by insiders? 1.22% of CVS Health stock is owned by insiders. Learn more on CVS's insider holdings. Which CVS Health insiders have been buying company stock? The following insiders have purchased CVS shares in the last 24 months: Edward J Ludwig ($194,820.00), Guy P Sansone ($100,009.00), and Michael F Mahoney ($2,001,000.00). How much insider buying is happening at CVS Health? Insiders have purchased a total of 34,570 CVS shares in the last 24 months for a total of $2,295,829.00 bought. Which CVS Health insiders have been selling company stock? The following insiders have sold CVS shares in the last 24 months: James David Clark ($498,487.55), and Prem S Shah ($2,267,947.35). How much insider selling is happening at CVS Health? Insiders have sold a total of 36,986 CVS Health shares in the last 24 months for a total of $2,766,434.90 sold. Which members of congress are trading CVS Health? Robert Bresnahan, Jr. (R-PA) and Gilbert Ray Cisneros, Jr. (D-CA) have bought shares of CVS Health in the last year totaling $16,000. Michael T. McCaul (R-TX), Ro Khanna (D-CA), Robert Bresnahan, Jr. (R-PA), Jefferson Shreve (R-IN), Julie Johnson (D-TX), J. French Hill (R-AR), Thomas R. Suozzi (D-NY), and Tommy Tuberville (R-AL) have sold shares totaling $471,000. CVS Health Key ExecutivesMs. Karen Sue Lynch (Age 61)President, CEO & Director Compensation: $5.12MMr. Thomas Francis Cowhey (Age 52)Executive VP & CFO Compensation: $1.83MMr. Tilak Mandadi (Age 59)Executive VP of Ventures and Chief Digital, Data, Analytics & Technology Officer Compensation: $2.38MMr. Samrat S. Khichi Esq. (Age 57)Executive VP, Chief Policy Officer & General Counsel Compensation: $3.39MMr. Prem S. Shah Pharm.D (Age 44)Executive VP, Chief Pharmacy Officer and President of Pharmacy & Consumer Wellness Compensation: $2.58MMr. Vijay PatelSenior Director of Business Development & CVS Health and Partner & Co-FounderMr. James David Clark (Age 59)Senior VP, Controller & Chief Accounting Officer 1 recent tradesMr. David A. FalkowskiExecutive VP & Chief Compliance OfficerMs. Heidi B. Capozzi (Age 54)Executive VP & Chief People Officer Mr. J. David Joyner CEBS (Age 59)Executive Vice President & President of CVS Caremark More Insider Trading Tools from MarketBeat Related Companies Amazon.com Insider Buying Walgreens Boots Alliance Insider Buying Cigna Group Insider Buying Humana Insider Buying UnitedHealth Group Insider Buying Walmart Insider Buying Danaher Insider Buying Elevance Health Insider Buying Cencora Insider Buying Labcorp Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Strategy Insiders Buy In While Analysts Predict Big UpsideThe Bottom Is in For These 3 Small-Cap Stocks Insiders Are Buying3 Catalysts Driving Plug Power’s Turnaround CaseInsider Selling Hits Market Leaders—Should You Be Worried?Insiders Spent Millions on These 3 Stocks Over the Past 2 Months This page (NYSE:CVS) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVS Health Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CVS Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
